PURPOSE: Pulmonary support (PS) on day-of-life-30 (DOL-30) has been shown to be the strongest predictor of subsequent morbidity and in-patient mortality in congenital diaphragmatic hernia (CDH). We hypothesized that PS on DOL-30 can also predict long-term outcomes in CDH survivors. METHODS: We analyzed records of 201 CDH survivors followed by a single multidisciplinary clinic (1995-2010). Follow-up was 83 and 70% at 1 and 5years respectively. PS was defined as: (1) invasive support (n=44), (2) noninvasive support (n=54), or (3) room air (n=103). Logistic regression was used to estimate the adjusted association of PS on DOL-30 with outcomes at 1 and 5-years. RESULTS: Use of PS on DOL-30 was significantly associated with pulmonary and developmental morbidities at 1 and 5-years. Even after adjusting for defect-size and presence of ventilation/perfusion mismatch, greater PS on DOL-30 was associated with a significantly increased odds of requiring supplemental oxygen and developmental referral at 1-year, and asthma and developmental referral at 5-years. CONCLUSION: CDH survivors continue to have significant long-term pulmonary and developmental morbidities. PS on DOL-30 is a strong independent predictor of morbidity at 1 and 5-years and may be used as a simple prognostic tool to identify high-risk infants.
PURPOSE: Pulmonary support (PS) on day-of-life-30 (DOL-30) has been shown to be the strongest predictor of subsequent morbidity and in-patient mortality in congenital diaphragmatic hernia (CDH). We hypothesized that PS on DOL-30 can also predict long-term outcomes in CDH survivors. METHODS: We analyzed records of 201 CDH survivors followed by a single multidisciplinary clinic (1995-2010). Follow-up was 83 and 70% at 1 and 5years respectively. PS was defined as: (1) invasive support (n=44), (2) noninvasive support (n=54), or (3) room air (n=103). Logistic regression was used to estimate the adjusted association of PS on DOL-30 with outcomes at 1 and 5-years. RESULTS: Use of PS on DOL-30 was significantly associated with pulmonary and developmental morbidities at 1 and 5-years. Even after adjusting for defect-size and presence of ventilation/perfusion mismatch, greater PS on DOL-30 was associated with a significantly increased odds of requiring supplemental oxygen and developmental referral at 1-year, and asthma and developmental referral at 5-years. CONCLUSION: CDH survivors continue to have significant long-term pulmonary and developmental morbidities. PS on DOL-30 is a strong independent predictor of morbidity at 1 and 5-years and may be used as a simple prognostic tool to identify high-risk infants.
Authors: L van den Hout; I Reiss; J F Felix; W C J Hop; Pamela A Lally; Kevin P Lally; D Tibboel Journal: Neonatology Date: 2010-10-30 Impact factor: 4.035
Authors: Raul A Cortes; Roberta L Keller; Tiffany Townsend; Michael R Harrison; Diana L Farmer; Hanmin Lee; Robert E Piecuch; Carol H Leonard; Maria Hetherton; Robin Bisgaard; Kerilyn K Nobuhara Journal: J Pediatr Surg Date: 2005-01 Impact factor: 2.545
Authors: Marlous J Madderom; Leontien Toussaint; Monique H M van der Cammen-van Zijp; Saskia J Gischler; René M H Wijnen; Dick Tibboel; Hanneke Ijsselstijn Journal: Arch Dis Child Fetal Neonatal Ed Date: 2012-12-12 Impact factor: 5.747
Authors: Akane Iguchi; Deborah A Ridout; Sonsoles Galan; Carole Bodlani; Katie Squire; Maura O'Callaghan; Kate L Brown Journal: Pediatr Crit Care Med Date: 2013-07 Impact factor: 3.624
Authors: Kevin P Lally; Pamela A Lally; Robert E Lasky; Dick Tibboel; Tom Jaksic; Jay M Wilson; Bjorn Frenckner; Krista P Van Meurs; Desmond J Bohn; Carl F Davis; Ronald B Hirschl Journal: Pediatrics Date: 2007-09 Impact factor: 7.124
Authors: Catherine Chen; Stefanie Jeruss; Jocelyn S Chapman; Norma Terrin; Hocine Tighiouart; Erik Glassman; Jay M Wilson; Susan K Parsons Journal: J Pediatr Surg Date: 2007-04 Impact factor: 2.545
Authors: Ruth B Seabrook; Theresa R Grover; Natalie Rintoul; Mark Weems; Sarah Keene; Beverly Brozanski; Robert DiGeronimo; Beth Haberman; Holly Hedrick; Jason Gien; Noorjahan Ali; Rachel Chapman; John Daniel; H Allen Harrison; Yvette Johnson; Nicolas F M Porta; Michael Uhing; Isabella Zaniletti; Karna Murthy Journal: J Perinatol Date: 2021-03-01 Impact factor: 2.521
Authors: Augusto Zani; Wendy K Chung; Jan Deprest; Matthew T Harting; Tim Jancelewicz; Shaun M Kunisaki; Neil Patel; Lina Antounians; Pramod S Puligandla; Richard Keijzer Journal: Nat Rev Dis Primers Date: 2022-06-01 Impact factor: 52.329
Authors: Alba Perez Ortiz; Anna Glauner; Felix Dittgen; Thalia Doniga; Svetlana Hetjens; Thomas Schaible; Neysan Rafat Journal: Front Pediatr Date: 2022-07-08 Impact factor: 3.569